James A. Hebda

942 total citations
9 papers, 821 citations indexed

About

James A. Hebda is a scholar working on Physiology, Molecular Biology and Biomaterials. According to data from OpenAlex, James A. Hebda has authored 9 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in James A. Hebda's work include Alzheimer's disease research and treatments (8 papers), Protein Structure and Dynamics (5 papers) and Supramolecular Self-Assembly in Materials (5 papers). James A. Hebda is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Protein Structure and Dynamics (5 papers) and Supramolecular Self-Assembly in Materials (5 papers). James A. Hebda collaborates with scholars based in United States, United Kingdom and India. James A. Hebda's co-authors include Andrew D. Miranker, Jefferson D. Knight, Ishu Saraogi, Andrew D. Hamilton, Lara A. Estroff, Jorge Becerril, Mazin Magzoub, Sunil Kumar, Diana E. Schlamadinger and Brandon Q. Mercado and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemistry and Biophysical Journal.

In The Last Decade

James A. Hebda

9 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Hebda United States 8 622 515 166 96 95 9 821
Erika Andreetto Germany 16 549 0.9× 543 1.1× 228 1.4× 66 0.7× 59 0.6× 21 851
Sharadrao M. Patil United States 13 407 0.7× 286 0.6× 73 0.4× 54 0.6× 74 0.8× 19 646
Lydia Young United Kingdom 10 512 0.8× 480 0.9× 118 0.7× 51 0.5× 73 0.8× 13 812
Takuma Okada Japan 9 448 0.7× 396 0.8× 162 1.0× 43 0.4× 44 0.5× 10 661
Andrea Gohlke United Kingdom 10 442 0.7× 268 0.5× 71 0.4× 46 0.5× 136 1.4× 18 643
Lise Giehm Denmark 12 547 0.9× 477 0.9× 95 0.6× 19 0.2× 88 0.9× 17 1.0k
Risto Cukalevski Sweden 12 508 0.8× 433 0.8× 293 1.8× 37 0.4× 34 0.4× 13 839
Anke Schmauder Germany 8 239 0.4× 263 0.5× 84 0.5× 41 0.4× 45 0.5× 8 438
Hans Meeldijk Netherlands 5 310 0.5× 297 0.6× 96 0.6× 32 0.3× 66 0.7× 5 478
Francesco Bemporad Italy 19 939 1.5× 628 1.2× 130 0.8× 42 0.4× 191 2.0× 45 1.2k

Countries citing papers authored by James A. Hebda

Since Specialization
Citations

This map shows the geographic impact of James A. Hebda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Hebda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Hebda more than expected).

Fields of papers citing papers by James A. Hebda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Hebda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Hebda. The network helps show where James A. Hebda may publish in the future.

Co-authorship network of co-authors of James A. Hebda

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Hebda. A scholar is included among the top collaborators of James A. Hebda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Hebda. James A. Hebda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kumar, Sunil, Diana E. Schlamadinger, Brandon Q. Mercado, et al.. (2015). Islet Amyloid-Induced Cell Death and Bilayer Integrity Loss Share a Molecular Origin Targetable with Oligopyridylamide-Based α-Helical Mimetics. Chemistry & Biology. 22(3). 369–378. 53 indexed citations
2.
Hebda, James A., Mazin Magzoub, & Andrew D. Miranker. (2014). Small molecule screening in context: Lipid‐catalyzed amyloid formation. Protein Science. 23(10). 1341–1348. 15 indexed citations
3.
Schlamadinger, Diana E., Sunil Kumar, Mazin Magzoub, James A. Hebda, & Andrew D. Miranker. (2013). Inhibition and Mechanism of Islet Amyloid Polypeptide Toxicity. Biophysical Journal. 104(2). 56a–56a. 1 indexed citations
4.
Hebda, James A., Ishu Saraogi, Mazin Magzoub, Andrew D. Hamilton, & Andrew D. Miranker. (2009). A Peptidomimetic Approach to Targeting Pre-amyloidogenic States in Type II Diabetes. Chemistry & Biology. 16(9). 943–950. 84 indexed citations
5.
Saraogi, Ishu, James A. Hebda, Jorge Becerril, et al.. (2009). Synthetic α‐Helix Mimetics as Agonists and Antagonists of Islet Amyloid Polypeptide Aggregation. Angewandte Chemie International Edition. 49(4). 736–739. 108 indexed citations
6.
Hebda, James A. & Andrew D. Miranker. (2009). The Interplay of Catalysis and Toxicity by Amyloid Intermediates on Lipid Bilayers: Insights from Type II Diabetes. Annual Review of Biophysics. 38(1). 125–152. 201 indexed citations
7.
Saraogi, Ishu, James A. Hebda, Jorge Becerril, et al.. (2009). Synthetic α‐Helix Mimetics as Agonists and Antagonists of Islet Amyloid Polypeptide Aggregation. Angewandte Chemie. 122(4). 748–751. 32 indexed citations
8.
Hebda, James A., et al.. (2008). Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. Protein Engineering Design and Selection. 21(3). 147–154. 55 indexed citations
9.
Knight, Jefferson D., James A. Hebda, & Andrew D. Miranker. (2006). Conserved and Cooperative Assembly of Membrane-Bound α-Helical States of Islet Amyloid Polypeptide. Biochemistry. 45(31). 9496–9508. 272 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026